-
AMAG Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Amag Pharmaceuticals (AMAG)
Company Profile
Quarter (USD) | Sep 20 | Jun 20 | Mar 20 | Sep 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 19 | Dec 18 | Dec 17 | Dec 16 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 98.48 mm | 98.48 mm | 98.48 mm | 98.48 mm | 98.48 mm | 98.48 mm |
Cash burn (monthly) | 179.00 k | 4.37 mm | (no burn) | 4.03 mm | (no burn) | 1.34 mm |
Cash used (since last report) | 9.09 mm | 222.16 mm | n/a | 204.79 mm | n/a | 67.91 mm |
Cash remaining | 89.39 mm | -123.68 mm | n/a | -106.31 mm | n/a | 30.57 mm |
Runway (months of cash) | 499.4 | -28.3 | n/a | -26.4 | n/a | 22.9 |
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|